Literature DB >> 20570556

Oculomotor deficits caused by 0.06% and 0.10% blood alcohol concentrations and relationship to subjective perception of drunkenness.

Per-Anders Fransson1, Fredrik Modig, Mitesh Patel, Stephen Gomez, Måns Magnusson.   

Abstract

OBJECTIVE: The visual system is vital during critical activities such as driving. Studying how alcohol compromises the visual system physiologically is therefore important for safety reasons. The objective of the study was to investigate alcohol-related impairments in visual tasks performed under controlled breath alcohol concentrations (BAC) to determine dose-dependent effects.
METHODS: Alcohol's effects on smooth pursuit and saccadic eye movements at 0.06% and 0.10% BAC were examined whilst recording alcohol levels by real-time measurements using a high precision breath analyzer. Oculomotor performance was recorded from 25 subjects by electronystagmography comprising measurements of smooth pursuit gain, saccade velocity, saccade accuracy and two novel parameters further describing oculomotor performance.
RESULTS: Alcohol deteriorated accuracy of smooth pursuit movements (p<0.001) and saccadic velocities (p<0.01) at 0.06% BAC. At 0.10% BAC, smooth pursuit gains (p<0.01), saccade accuracies and saccade latencies (p<0.01) were also affected. The ratio between saccade velocity and saccade amplitude decreased significantly under alcohol intoxication (p<0.01). Self-perceptions of drunkenness correlated well with changes in smooth pursuit accuracy, but poorly with other oculomotor measures.
CONCLUSIONS: Several of the smooth pursuit and saccade functions were altered dose-dependently by alcohol and small changes in BAC substantially changed the effects observed. Additionally, alcohol altered the relationship between saccade velocity and saccade amplitude, diminishing the capacity for saccades to reach high peak velocities. SIGNIFICANCE: The alcohol-induced oculomotor deficits, which were found already at 0.06% BAC by our more sensitive analysis methods, may have safety implications for tasks that rely on visual motor control and visual feedback.
Copyright © 2010 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570556     DOI: 10.1016/j.clinph.2010.05.003

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  Decreased postural control in adolescents born with extremely low birth weight.

Authors:  Hannes Petersen; Arnar-Thor Tulinius; Ingibjörg Georgsdóttir; Einar-Jon Einarsson; Mitesh Patel; Ásgeir Haraldsson; Per-Anders Fransson
Journal:  Exp Brain Res       Date:  2015-03-14       Impact factor: 1.972

2.  Deleterious effects of a low amount of ethanol on LTP-like plasticity in human cortex.

Authors:  Caroline Lücke; Tonio Heidegger; Mirjam Röhner; Stefan W Toennes; Lucia Krivanekova; Florian Müller-Dahlhaus; Ulf Ziemann
Journal:  Neuropsychopharmacology       Date:  2014-01-02       Impact factor: 7.853

3.  Clinical Characterization of Oculomotricity in Children with and without Specific Learning Disorders.

Authors:  Carmen Bilbao; David P Piñero
Journal:  Brain Sci       Date:  2020-11-11

4.  Dose-dependent sensorimotor impairment in human ocular tracking after acute low-dose alcohol administration.

Authors:  Terence L Tyson; Nathan H Feick; Patrick F Cravalho; Erin E Flynn-Evans; Leland S Stone
Journal:  J Physiol       Date:  2020-12-17       Impact factor: 5.182

5.  Subthalamic deep brain stimulation improves smooth pursuit and saccade performance in patients with Parkinson's disease.

Authors:  Maria H Nilsson; Mitesh Patel; Stig Rehncrona; Måns Magnusson; Per-Anders Fransson
Journal:  J Neuroeng Rehabil       Date:  2013-04-03       Impact factor: 4.262

6.  Oculomotor Deficits after Chemotherapy in Childhood.

Authors:  Einar-Jón Einarsson; Mitesh Patel; Hannes Petersen; Thomas Wiebe; Måns Magnusson; Christian Moëll; Per-Anders Fransson
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.